Barbara K. Burton, MD

Clinical and Community Trials

Research Interests

  • Phenylketonuria
  • Lysosomal Storage Disorder
  • Inborn Errors of Metabolism

Biography

  • Attending Physician, Genetics, Birth Defects, and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Professor of Pediatrics (Genetics, Birth Defects, and Metabolism), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

See Full Listing of Publications

Education and Background

  • Children's Memorial Hospital 1973-1977
  • MD, Northwestern University 1973

Clinical Studies

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Mucopolysaccharidosis VII Disease Monitoring Program

See All Studies

Publications

Mar. 03, 2024

Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registries.

Dec. 24, 2023

Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.

Nov. 16, 2023

Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.

See all publications